Cardiovascular Evaluation in Homozygous Familial Hypercholesterolemia Patients
The study aims to observe and describe heart health over time using noninvasive methods in individuals with homozygous familial hypercholesterolemia who have specific LDL receptor defects.
Data Collection
Collected from today forward - ProspectiveArterial Occlusive Diseases+8
+ Arteriosclerosis
+ Cardiovascular Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: January 7, 1992
Actual date on which the first participant was enrolled.Familial hypercholesterolemia is a serious genetic condition where the body has trouble handling cholesterol properly, leading to very high levels of "bad" cholesterol, known as LDL, in the blood. This can cause heart disease at an early age. The purpose of this study is to carefully examine the heart health of people with a severe form of this condition, where both copies of the gene are affected. This research aims to understand how heart disease progresses in these patients and to explore who might benefit from treatments like liver transplants or new genetic therapies. Understanding this can lead to better management and potentially life-extending treatments for affected individuals. The study involves regular heart check-ups using techniques that do not involve surgery or entering the body, which are called noninvasive methods. These assessments will be repeated over time to track changes in the heart's condition. By gathering detailed information on how the disease affects the heart, researchers hope to identify those who might experience significant improvements with advanced treatments. The study does not involve any experimental treatment, but instead focuses on collecting detailed data to inform future therapeutic decisions.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.73 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 2 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
* INCLUSION CRITERIA: Fasting cholesterol greater than 500 mg/dl, low density lipoprotein cholesterol greater than 400 mg/dl, and triglycerides less than mg/dl. Family history of hypercholesterolemia and/or cardiovascular disease before the age of 60 years. Tendinous and tuberous xanthomas. Arcus corneae before the age of 30.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Institutes of Health Clinical Center
Bethesda, United StatesOpen National Institutes of Health Clinical Center in Google Maps